| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 11/30/2005 | CN1229331C Inhibitor of monoamine uptake |
| 11/30/2005 | CN1229142C NSAID and EFGR kinase inhibitor contg. compsn. for treatment or inhibition of colonic polyps and colorectal cancer |
| 11/30/2005 | CN1229138C Method for accelerating rate of mucociliary clearance |
| 11/30/2005 | CN1229137C New therapeutic uses of SMR1 peptides |
| 11/30/2005 | CN1229032C Process and production for promoting weight loss for overweight dogs |
| 11/29/2005 | US6969729 An indole or benz(g)indole-2,3-dione-3-oxime compounds; therapeutic treatment of respiratory disorders, urogenital disorders, cardiovascular disorders, brain and psychological disorders, gastrointestinal disorders |
| 11/29/2005 | US6969728 Antiinflammatory agents |
| 11/29/2005 | US6969724 Compounds |
| 11/29/2005 | US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system |
| 11/29/2005 | US6969720 2,6,9-trisubstituted purine derivatives which are inhibitors of cyclin/cdk (cyclin dependent kinases) complexes |
| 11/29/2005 | US6969719 Such as 3-((3-bromo-4-hydroxyphenyl)methyl)-5-ethyl-7,8-dihydro-2-(tetrahydro-2H -pyran-4-yl)amino)-3H-imidazo(2,1-b) purin-4(5H)-one for treating sexual disorders |
| 11/29/2005 | US6969718 17-β hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 11/29/2005 | US6969717 Azaindole kinase inhibitors |
| 11/29/2005 | US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade |
| 11/29/2005 | US6969714 Imidazolo-5-YL-2-anilino-pyrimidines as agents for the inhibition of the cell proliferation |
| 11/29/2005 | US6969712 Alzheimer's disease; central nervous system disorders; antidepressants; antidiabetic agents; analgesics |
| 11/29/2005 | US6969710 Compounds |
| 11/29/2005 | US6969707 For therapy or inhibiting the development of a pathology associated with peroxynitrite damage |
| 11/29/2005 | US6969517 Anticancer agents; genetic engineered fusion protein |
| 11/29/2005 | US6969516 Immunological compositions and methods of use to transiently alter mammalian central nervous system myelin to promote neuronal regeneration |
| 11/29/2005 | CA2355493C Therapeutic compositions comprising excess enantiomer |
| 11/29/2005 | CA2332513C New derivatives of 4-sulfonamide piperidine, preparation process thereof and the pharmaceutical compositions they contain |
| 11/29/2005 | CA2288445C 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 11/28/2005 | CA2508093A1 Preparation for external use on skin |
| 11/26/2005 | CA2503105A1 Use of lif in cosmetics and dermatology |
| 11/24/2005 | WO2005111021A1 Preparation of candesartan cilexetil in high purity |
| 11/24/2005 | WO2005111007A1 Thiazole compound and use thereof |
| 11/24/2005 | WO2005110476A1 Method of inhibiting telomerase activity and inhibitor |
| 11/24/2005 | WO2005110400A1 Lipase inhibitor, cholesterol esterase inhibtor, neutral fat absorption inhibitor, cholesterol absorption inhibitor and cholesterol ester absorption inhibitor |
| 11/24/2005 | WO2005110394A1 Therapeutic agent for diabetes |
| 11/24/2005 | US20050261501 e.g. 1-({[9-(hydroxymethyl)-3-oxaspiro[5.5]undec-9-yl]amino}acetyl)-2-pyrrolidinecarbonitrile; dipeptidyl-peptidase IV inhibitor; antidiabetic, hypoglycemic agent; non-insulin dependent diabetes, obesity |
| 11/24/2005 | US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis |
| 11/24/2005 | US20050261377 Methods of using rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfunction |
| 11/24/2005 | US20050261372 NMDA receptor agonist; neurodegenerative diseases, cognition activator; autism, schizophrenia, Alzheimer's disease; glycinergic and/or glutaminergic transmission activator |
| 11/24/2005 | US20050261371 Administering valproic acid or salts to treat Alzheimer's disease, amyotrophic lateral sclerosis, multiple sclerosis, stroke, and other nervous system disorders |
| 11/24/2005 | US20050261364 Stereoisomeric form and a second antiretroviral compound; treating multidrug resistant HIV infections; protein plasma binding of the protease inhibitor has minimal or no effect on its potency; effective over a broad range of HIV mutants, bioavailability |
| 11/24/2005 | US20050261363 Acetone extraction for gamboge resins for tumor purification for antitumor and anticancer agent cells with acetone extraction |
| 11/24/2005 | US20050261357 Brain dysfunction or neuropathy caused by loss or degeneration of the neuron; differentiation of a stem cell; 14-(5-methoxy-1H-indole-2-yl)-tetradecane-1-ol |
| 11/24/2005 | US20050261344 Treatment of lower urinary tract symptoms associated with overactive bladder in men and women |
| 11/24/2005 | US20050261343 Anthranilamides and their use as pharmaceutical agents |
| 11/24/2005 | US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia |
| 11/24/2005 | US20050261338 Beta2-adrenergic receptor agonists |
| 11/24/2005 | US20050261336 e.g. 8-hydroxy-2-[2-[3,4-dihydroxy-5-methoxyphenyl)ethenyl]]-7-quinoline carboxylic acid; HIV integrase inhibitors; AIDS, retroviral pathologies |
| 11/24/2005 | US20050261317 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 11/24/2005 | US20050261313 For angiogenesis mediated diseases; cancer; acylation, cyclization and Heck-type reduction |
| 11/24/2005 | US20050261305 Cyclic protein tyrosine kinase inhibitors |
| 11/24/2005 | US20050261297 Compound for stimulating bone growth |
| 11/24/2005 | US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 11/24/2005 | US20050261291 1-Cyclopropylmethyl-4-[2-(3,3,5,5-tetramethylcyclohexyl)phenyl]piperazine or a salt or hydrate; exhibit excellent cell adhesion inhibitory action or cell infiltration inhibitory action; for treating inflammatory diseases and autoimmune diseases such as inflammatory bowel diseases and rheumatoid arthritis |
| 11/24/2005 | US20050261285 Tetrahydropyran derivatives and their use as therapeutic agents |
| 11/24/2005 | US20050261283 Methods and compositions for the treatment of graft failure |
| 11/24/2005 | US20050261281 Pharmaceutical compounds |
| 11/24/2005 | US20050261280 Stabilized antihistamine syrup |
| 11/24/2005 | US20050261279 antipsychotic agents; phenylsulfonyl compounds; 7-Methoxy-8-(3-phenoxy-benzenesulfonyl)-2,3,4,5-tetrahydro-1H-3-benzazepine; schizophrenia |
| 11/24/2005 | US20050261277 Pentacyclic oxepines and derivatives thereof, compositions and methods |
| 11/24/2005 | US20050261271 Dipeptidyl peptidase inhibitors |
| 11/24/2005 | US20050261265 modulating cellular senescence in vitro by introducing a polynucleotide (gDNA or cDNA) encoding an amphiphysin-1 protein; genetic engineering; genetic disorders, premature aging |
| 11/24/2005 | US20050261252 LPA receptor agonists and antagonists and methods of use |
| 11/24/2005 | US20050261248 New-4-pyrrolopyrimidin-6-YL)benzenesulphonamide derivatives |
| 11/24/2005 | US20050261242 nitroso derivatives of drugs such as antiinflammatory agents, antibiotics, expectorants, mucolytic agents, antidiabetics, antitumor, viricides, enzyme inhibitors bronchodilators and antiulcer agents; oxidative and endothelial stress dysfunction; free radicals scavenger |
| 11/24/2005 | US20050261235 2' ,5' -Oligoadenylate analogs |
| 11/24/2005 | US20050261231 Improving tissue survival; methods for enhancing organ transplant, musculocutaneous flap or skin graft survival by administering a nucleic acid sequence encoding hepatocyte growth factor; neovascularization; surgery; tissue-targeted therapy |
| 11/24/2005 | US20050261187 Methods and compositions relating to MEK5 and cardiac hypertrophy and dilated cardiomyopathy |
| 11/24/2005 | US20050261186 NRG-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 11/24/2005 | US20050261182 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin |
| 11/24/2005 | US20050261178 Administering to patient therapeutic dose of cytokine in combination with antibodies directed against tumor associated antigen carbonic anhydrase IX (CAIX/G250/MN); method characterized in significantly reduced cytokine-related toxicity combined with potentiated effectiveness of anti-G250 antibody alone |
| 11/24/2005 | US20050261165 compounds that inhibit activity of the AcrAB or AcrAB-like efflux pump are identified as compounds which reduce antibiotic resistance in a microbe that has 2 chromosomal mutations in a gene encoding an antibiotic target that renders it resistant and increased expression of at least one efflux pump |
| 11/24/2005 | US20050261164 Remedy for urinary frequency and urinary incontinence |
| 11/24/2005 | US20050260767 Treatment with cytokines |
| 11/24/2005 | US20050260753 Cross-linked hyaluronic acid-laminin gels and use thereof in cell culture and medical implants |
| 11/24/2005 | US20050260747 Embryonic stem cells and neural progenitor cells derived therefrom |
| 11/24/2005 | US20050260732 Polypeptide crystal having a polyhistidine tag added to the C-terminal end; effectors; drug screening for enzyme inhibitors; multiple sclerosis, diabetes, Grave's disease, rheumatic arthritis, AIDS, cancer, immunomodulators |
| 11/24/2005 | US20050260708 Proteases and protease inhibitors |
| 11/24/2005 | US20050260644 Cell signaling proteins |
| 11/24/2005 | US20050260582 Cell proliferation inhibitors comprising ets transcription factor or gene encoding the same |
| 11/24/2005 | US20050260579 TGF-beta type receptor cDNAs encoded products |
| 11/24/2005 | US20050260575 Method for identifying substances useful for treating inflammation using the response element to the ikbalpha ror receptor |
| 11/24/2005 | US20050260277 Method and formula for anti-tumor and anti-matastatic effect |
| 11/24/2005 | US20050260261 Neutral-cationic lipid for nucleic acid and drug delivery |
| 11/24/2005 | US20050260228 Vaccines absorbable by the transmucosal way |
| 11/24/2005 | US20050260216 Polypeptide containing a mutation characteristic of an analogous non-human protein; is capable of raising antibodies in human, antibodies bind to both the human protein and the polypeptide |
| 11/24/2005 | US20050260209 Ephrin-b receptor protein involved in carcinoma |
| 11/24/2005 | US20050260185 Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase |
| 11/24/2005 | US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
| 11/24/2005 | CA2566625A1 Thiazole compound and use thereof |
| 11/24/2005 | CA2562597A1 Preparation of candesartan cilexetil in high purity |
| 11/24/2005 | CA2508065A1 Antiproliferative drug and delivery device |
| 11/24/2005 | CA2507712A1 Pharmaceutical compounds |
| 11/24/2005 | CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators |
| 11/23/2005 | EP1598420A2 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 11/23/2005 | EP1598365A1 Protection of endogenous therapeutic peptides |
| 11/23/2005 | EP1598355A1 Therapeutic agent for schizophrenia |
| 11/23/2005 | EP1598350A1 Pyrrolidines and thiazolidines derivatives, their preparation and their use in the treatment of hyperglycaemia and of type II Diabetis |
| 11/23/2005 | EP1598349A1 Novel 2-pyridinecarboxamide derivatives |
| 11/23/2005 | EP1598346A1 Process for producing acid adduct salt of polyacidic base compound |
| 11/23/2005 | EP1598340A1 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain |
| 11/23/2005 | EP1598339A1 1-(4-amino-cyclohexyl)-1,3-dihydro-2h-benzimidazole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain |
| 11/23/2005 | EP1598338A1 1-(4-piperidinyl)-1,3-dihydro-2h-indole-2-one derivatives and related compounds as nociceptin analogs and orl1 ligands for the treatment of pain |
| 11/23/2005 | EP1598335A1 Prostaglandin derivatives |
| 11/23/2005 | EP1598077A1 Use of the neurotoxic component of botulinum toxins for the treatment of a spastic muscle |